Together we are beating cancer

Donate now

Myeloma

Showing 12 out of 23 results
Multiple myeloma is an incurable malignancy of immunoglobulin-secreting plasma cells

Lessons must be learnt from the personalised medicine revolution in solid cancers if we are to push treatment of multiple myeloma forward Lessons must be learnt from the personalised medicine revolution in solid cancers if we are to push treatment of multiple myeloma forward

by Cancer Research UK | In depth | 8 January 2024

8 January 2024

Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important… Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important…

by Cancer Research UK | In depth | 30 October 2023

30 October 2023

Alive (green) and dead (red) myeloma cells under the microscope.

A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’. A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’.

by Eleanor Bennett | Analysis | 29 April 2021

29 April 2021

Lung cancer cell

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma. The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

by Cancer Research UK | News | 21 January 2021

21 January 2021